Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

References for PMC Articles for PubMed (Select 21897916)

1.

Current perceptions of the epidemiology of atrial fibrillation.

Kannel WB, Benjamin EJ.

Cardiol Clin. 2009 Feb;27(1):13-24, vii. doi: 10.1016/j.ccl.2008.09.015. Review.

2.

High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study.

Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, den Heijer M, Visser TJ, Witteman JC.

Arch Intern Med. 2008 Nov 10;168(20):2219-24. doi: 10.1001/archinte.168.20.2219.

PMID:
19001198
3.

Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation.

Soran H, Younis N, Currie P, Silas J, Jones IR, Gill G.

QJM. 2008 Mar;101(3):181-7. doi: 10.1093/qjmed/hcm123. Epub 2008 Jan 17.

4.

Status of the epidemiology of atrial fibrillation.

Kannel WB, Benjamin EJ.

Med Clin North Am. 2008 Jan;92(1):17-40, ix. Review.

5.

Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004.

McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA Jr.

Ann Emerg Med. 2008 Jan;51(1):58-65. Epub 2007 Apr 27.

PMID:
17466409
6.

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.

Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ.

J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33. Epub 2007 Apr 19.

7.

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.

Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC.

Eur Heart J. 2006 Apr;27(8):949-53. Epub 2006 Mar 9.

8.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ.

J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9.

9.

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cerè E, Tognoni G, Cohn JN; Val-HeFT Investigators.

Am Heart J. 2005 Mar;149(3):548-57.

PMID:
15864246
10.

Diabetes mellitus in Saudi Arabia.

Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, Khan NB, Al-Khadra A, Al-Marzouki K, Nouh MS, Abdullah M, Attas O, Al-Shahid MS, Al-Mobeireek A.

Saudi Med J. 2004 Nov;25(11):1603-10.

PMID:
15573186
11.

Obesity and the risk of new-onset atrial fibrillation.

Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ.

JAMA. 2004 Nov 24;292(20):2471-7.

PMID:
15562125
12.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ.

Circulation. 2004 Aug 31;110(9):1042-6. Epub 2004 Aug 16.

13.

Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.

Frost L, Vestergaard P, Mosekilde L.

Arch Intern Med. 2004 Aug 9-23;164(15):1675-8. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):307.

PMID:
15302638
14.

Atrial fibrillation: an emerging epidemic?

Steinberg JS.

Heart. 2004 Mar;90(3):239-40. No abstract available.

15.

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.

Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A.

Circulation. 2003 Jun 17;107(23):2926-31. Epub 2003 May 27.

16.
17.

Increased atrial fibrillation mortality: United States, 1980-1998.

Wattigney WA, Mensah GA, Croft JB.

Am J Epidemiol. 2002 May 1;155(9):819-26.

18.

Clinical trends in atrial fibrillation at the turn of the millenium.

Savelieva I, Camm AJ.

J Intern Med. 2001 Nov;250(5):369-72. No abstract available.

PMID:
11887970
19.

Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B.

Am Heart J. 2001 Nov;142(5):838-42.

PMID:
11685172
20.

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ.

JAMA. 2001 Jun 13;285(22):2864-70.

PMID:
11401607
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk